Autopsy report · NCT00483600

Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction

“unable to enroll”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Duke University

Sponsor type

University, hospital or other

Conditions

Kidney Diseases

Interventions

fondaparinux

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Surgical PA-LAA Shunting: a Feasibility Study
  “Failure to enroll” (93% match in meaning)
• Mobility and Activity Training (MAT) to Optimize Outcomes for Older Adult Abdominal Surgery Patients
  “Difficulty enrolling” (89% match in meaning)
• Physica System KR Vs Physica System CR (K-20)
  “Problems with enrollement” (88% match in meaning)
• Cervical Ripening in Postmenopausal Women
  “not able to meet enrollment” (88% match in meaning)
• Inferior Vena Cava (IVC) Diameters Before & After Interscalene Block
  “unable to enroll subjects” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.